We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$56.8M +$7.56M +108,628 +22%
AIM
2
ARK Investment Management
Florida
$35.1M +$5.56M +79,906 +27%
RG
3
Redmile Group
California
$33.5M +$13.8M +197,518 +120%
FP
4
Flagship Pioneering
Massachusetts
$29.7M
NAMA
5
Nikko Asset Management Americas
New York
$27.7M +$16M +230,328 +337%
BlackRock
6
BlackRock
New York
$24.7M +$4.57M +65,674 +33%
Vanguard Group
7
Vanguard Group
Pennsylvania
$16.3M +$6.01M +86,307 +96%
SB
8
Samsara BioCapital
California
$15.2M +$4.64M +66,666 +63%
Sumitomo Mitsui Trust Group
9
Sumitomo Mitsui Trust Group
Japan
$14.7M +$6.3M +90,457 +132%
DM
10
Deerfield Management
New York
$11.8M
BBA
11
Baker Bros. Advisors
New York
$9.03M +$2.79M +40,000 +70%
State Street
12
State Street
Massachusetts
$5.22M +$992K +14,244 +34%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$4.39M +$774K +11,118 +31%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$4.13M +$1.08M +15,539 +53%
6CM
15
683 Capital Management
New York
$3.98M +$2.99M +42,978 New
JP Morgan Chase
16
JP Morgan Chase
New York
$3.24M +$47.1K +677 +2%
Northern Trust
17
Northern Trust
Illinois
$3.07M +$175K +2,520 +8%
Alyeska Investment Group
18
Alyeska Investment Group
Illinois
$2.94M +$2.21M +31,747 New
Renaissance Technologies
19
Renaissance Technologies
New York
$2.75M +$535K +7,690 +35%
EC
20
EcoR1 Capital
California
$2.3M +$1.73M +24,848 New
Charles Schwab
21
Charles Schwab
California
$1.89M +$634K +9,108 +81%
CS
22
Candriam SCA
Luxembourg
$1.56M -$244K -3,500 -17%
T. Rowe Price Associates
23
T. Rowe Price Associates
Maryland
$1.32M -$103K -1,485 -9%
Nuveen
24
Nuveen
North Carolina
$1.04M +$780K +11,200 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$981K +$158K +2,266 +27%